Home

Cardionovum’s Restore paclitaxel-coated balloon for coronary applications has received market approval for use in China. It can be used in treating two indications: in-stent restenosis and small vessel disease. A joint press release from Cardionovum and China Grand Pharmaceutical and Healthcare Holdings states that the Restore device features the company’s SafePax next-generation, stable, homogeneous, paclitaxel coating. It says that SafePax is an amorphous, noncrystalline matrix that is not affected by mechanical stress due to elastic, lipophilic, polymeric excipients.

The joint statement also says that the approval was supported by results from two multicentre, randomised controlled trials in Chinese populations: RESTORE ISR CHINA and RESTORE SVD CHINA.

RESTORE ISR CHINA consisted of 240 patients with coronary ISR at 12 sites in China. The performance of the Restore DCB matched the Sequent Please DCB (B. Braun Interventional Systems) on both in-segment and in-device late lumen losses at nine months after the procedure and on rates of target lesion failure at one year.

RESTORE SVD CHINA studied 262 patients with coronary small vessel lesions at 12 sites. It found that the Restore DCB was noninferior to the latest-generation Resolute zotarolimus-eluting stent (Medtronic) on percent-diameter restenosis at nine months, as well as on rates of target lesion failure at one and two years.

Additionally, according to the press release, a substudy of patients with very small vessels (≥ 2mm and < 2.25mm) demonstrated that Restore was successfully employed with a very low procedural complication rate and no death, myocardial infarction, or thrombotic events.

Marina Izzo, CEO of Cardionovum, says in the statment: “At Cardionovum, we are passionate about driving the future and Restore is one of our most innovative products. I am very proud of the Chinese elite investigators whose hard work laid the foundation for this approval. RESTORE is the first and only DCB available in China to treat SVD. This is a great honour for us and a validation of our focus on performance-driven quality.”

Cardionovum is a medical technology company based in Bonn, Germany, that develops and commercialises medical devices such as new generation of DCB and drug eluting stents for the treatment of coronary and peripheral artery disease. China Grand Pharmaceutical and Healthcare Holdings is an investment holding company engaged in the development, manufacture and sale of pharmaceutical preparations, medical devices, pharmaceutical intermediates, specialised raw materials and healthcare products.

Source CardiovascularNews

Duc Tin Clinic

Chia sẽ qua facebook bài: Cardionovum’s coronary DCB receives regulatory approval in China

Chia sẽ qua google bài: Cardionovum’s coronary DCB receives regulatory approval in China

Chia sẽ qua twitter bài: Cardionovum’s coronary DCB receives regulatory approval in China

Chia sẽ qua MySpace bài: Cardionovum’s coronary DCB receives regulatory approval in China

Chia sẽ qua LinkedIn bài: Cardionovum’s coronary DCB receives regulatory approval in China

Chia sẽ qua stumbleupon bài: Cardionovum’s coronary DCB receives regulatory approval in China

Chia sẽ qua icio bài: Cardionovum’s coronary DCB receives regulatory approval in China

Chia sẽ qua digg bài: Cardionovum’s coronary DCB receives regulatory approval in China

Chia sẽ qua yahoo bài: Cardionovum’s coronary DCB receives regulatory approval in China

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.